FDA cleared the GANNET® from BAAT Medical Products B.V. on Oct 22, 2026 under K262184, a traditional 510(k). The device falls under product code JDO, Device, Fixation, Proximal Femoral, Implant, regulated at 21 CFR 888.3030 as a Class 2 device. The review panel was Orthopedic.

FDA logged the submission as received on Jun 29, 2026. The decision came 115 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

BAAT Medical Products B.V. has 2 other decisions in the tracker over the last 12 months: K254176 (SINEFIX), K251961 (SDS Growing Rod).